EVALUASI EKONOMI BIAYA PENANGANAN GAGAL GINJAL
Transcription
EVALUASI EKONOMI BIAYA PENANGANAN GAGAL GINJAL
COST EFFECTIVENESS ANALYSIS ON CHRONIC DIALYSIS : COMPARISON BETWEEN HAEMODIALYSIS AND CHRONIC AMBULATORY PERITONEAL DIALYSIS ELSA NOVELIA BPJS Kesehatan INA HEA, Jakarta 2015 BACKGROUND LITERATURE REVIEW FRAMEWORK CONSEPTS METHODOLOGY RESULT DISCUSSION CONCLUSION INA HEA, Jakarta 2015 2 BACKGROUN D Decreased renal function up with not being able to work in maintaining the balance of fluids/chemicals (Sherwood 2001) Damage of Renal > 3 months with pathology abnormalities, glomerular filtration rate < 60 ml/min (Chonchol 2005) INA HEA, Jakarta 2015 3 CLASSIFICATION OF CKD Penanda Tahapan CKD Kode CKD (ICD-9-CM) eGFR ≥90 ml/min/1.73 m2, ACR ≥30 mg/g eGFR 60–89, ACR ≥30 eGFR 30–59 eGFR 15–29 eGFR <15 585.1 Chronic kidney disease, Stage 1 585.2 Chronic kidney disease, Stage 2 (mild) 585.3 Chronic kidney disease, Stage 3 (moderate) 585.4 Chronic kidney disease, Stage 4 (severe) 585.5 Chronic kidney disease, Stage 5 Keterangan: ACR adalah Albumin/Creatinin Ratio Source: National Health and Nutrition Examination Survey (2002) INA HEA, Jakarta 2015 4 Worldwide 7% or 488 million CKD 1,6 million ESRD/CKD stage 5 America 12,3 %, 36 million CKD 117 thousand ESRD Indonesia 0,2% ESRD > 15 years old or 482 thousand inhabitant (Riskesdas 2013) INA HEA, Jakarta 2015 5 ESRD PATIENT AND VISIT TO HOSPITAL 2010 2011 2012 2013 ESRD number Ratio /100.000 members number Ratio/100.000 members number Ratio/100.000 members number Ratio/ 100.000 members Patient 26.455 159,8 23.261 141,1 24.362 148,7 25.975 160,9 Outpatient 28.546 172,4 52.614 319,2 54.512 332,7 54.092 335,2 Inpatient 12.533 75,7 23.911 145,1 26.703 162,9 28.829 178,6 Source: PT Askes Data (2013) INA HEA, Jakarta 2015 6 DM AND HYPERTENSION TOTAL OF PATIENT DIAGNOSIS DM HYPERTENSION 2010 2011 2012 2013 414.906 348.518 371.243 380.887 482.150 511.661 527.816 522.125 Sources: PT Askes Data (2013) INA HEA, Jakarta 2015 7 COST CONSEQUENCES OF ESRD TREATMENT 1 trillion USD in next 10 years (World Kidney Day Organisation 2013) 32 billion USD/year (Harvard Stem Cell Institute 2011) INA HEA, Jakarta 2015 8 COST OF ESRD Cost of ESRD (Billion RP) 482,07 417,68 336,20 231,51 2010 2011 2012 2013 Source: PT Askes Data (2013) INA HEA, Jakarta 2015 9 COST OF ESRD Year Cost of ESRD Cost of Health Care % cost of ESRD compare to cost of Health Care 2010 231,512,443,433.64 4,342,338,234,959 5,3% 2011 336,204,155,653.31 5,166,418,195,229 6,5% 2012 417,687,396,410.29 6,490,512,490,936 6,4% 2013 482,067,148,455.74 6,900,109,165,791 6,9% Source: PT Askes Data (2013) INA HEA, Jakarta 2015 10 COST OF RENAL REPLACEMENT Transplant 172 Million (Rp) + immunosuppressant drugs per year 68 Million HD 2 times a week, CAPD 53-70 5 hours, Million (Rp) + 54 – 72 (Rp) Million Catheter 10 Million Source: Karopadi (2013) INA HEA, Jakarta 2015 11 QUALITY OF LIFE Chronic Disease (ESRD) Poor Quality of Life Poor Mental Health INA HEA, Jakarta 2015 12 RENAL REPLACEMENT THERAPY WORLDWIDE CAPD INDONESIA CAPD 120 THOUSAND (2009) 800 OR 10 % OF HD (2009) INA HEA, Jakarta 2015 13 HD VS CAPD TREATMENT HD CAPD Ratio CAPD/HD 2010 2011 2012 334,382 408,800 491,520 6,571 6,464 7,497 2.0% 1.6% 1.5% 2013 557,095 8,645 1.6% Source: PT Askes Data (2013) INA HEA, Jakarta 2015 14 OBJECTIVE The aim of this study is to analize the cost effectiveness between HD and CAPD on ESRD patients HEMODIALISA CAPD INA HEA, Jakarta 2015 15 MAIN CAUSE OF CHRONIC KIDNEY DISEASE IN THE UNITED STATES (1995-1999) Caused Incident DM 44 % Hypertension and vascular disease 27% Glomerulonefritis 10% Nefritis Insterstitialis 4% Cyst and other congenital disease 3% Systemic Disease (ex Lupus and Vasculitis) 2% Neoplasma 2% Source: Buku ajar Ilmu Penyakit Dalam (2006) INA HEA, Jakarta 2015 16 CAUSED OF RENAL FAILURE WHO UNDERGOING HEMODIALYSIS IN INDONESIA Caused Incident Glomerulonefritis 46,39% DM 18,6% Obstruction and Infection 12,85% Hypertension and Infection 8,46% Others caused 13,65% source: Buku ajar Ilmu Penyakit Dalam (2006) INA HEA, Jakarta 2015 17 RENAL REPLACEMENT THERAPY No I Renal Replacement Dialysis A. Peritoneal Dialysis (DP) B. Hemodialysis II Renal Transplants Life Donor Funeral Donor Source: Buku ajar Ilmu Penyakit Dalam (2006) INA HEA, Jakarta 2015 18 CAPD HEMODIALYSIS INA HEA, Jakarta 2015 19 HEMODIALYSIS VS PERITONEAL DIALYSIS Benefit Hemodialysis Peritoneal Dialysis Done by a team of health professionals Gives more freedom than HD Be able to socialize with other hemodialysis patients who will Can be done at home, can be done at the time of travel, provide emotional support while sleeping Not be done alone as PD Can be done alone Done in fewer days than the PD Does not take a lot of food and fluid restriction as in HD It takes no needles Loss Cause fatigue during the HD session The procedure is quite difficult as some people Led to the emergence of problems such as low blood pressure, Increase the risk of infection peritonitis blood clots during dialysis access Increase the risk of bloodstream infection Source: (WebMD 2011) INA HEA, Jakarta 2015 20 PD Utilization > 80%, Government Policy ESTIMATION COST OF HD AND CAPD Average cost of HD Average cost of CAPD HD Reimburstment CAPD Reimburstment per month per month from Government from Government Banglades 370 454,5 68% 0% Cina 500 500 50-90% 50-90% 2,560 1,070 100% 100% India 160-280 325 0% 0% Indonesia 450-900 450 10-30% 40% Jepang 3,480 3,200 100% 100% Korea 1,160 1.100 80% 80% Malaysia 520 315 40% 100% Pakistan 300 800 70% 0% Singapura 1,001 618 80% 80% Sri Langka 324 700-800 60% 0% 1,615 1,032 100% 100% Country Hongkong Taiwan INA HEA, Jakarta 2015 Source: Departement of Medicine and Therapeutics (2001) 21 COST COMPARISON BETWEEN HEMODIALYSIS AND CAPD Country HD CAPD Swedia 99,084 74,880 USA In Center: 51,252 26,959 Satellite: 42,067 Self Care: 29,961 Hongkong 30,678 12,843 Turkey 22,759 22,350 Malaysia 8,853 8,325 Source: Departement of Medicine, Tung Wah Hospital, (2006) INA HEA, Jakarta 2015 Cost of PD less than HD, lower utillization, physician incentives, main reason in many countries (Kei Lo 2007) 22 QUALITY OF LIFE DIALYSIS PATIENT According to (Coccossis, et al., 2008) renal failure patients who received hemodialysis or peritoneal dialysis action / CAPD found to have a decreased quality of life, with different areas. Some studies showed that HD patients reported having better on physical quality, sleep and sexual relationship. For some mental study found that patients who commit acts of HD have more depressive symptoms compared with PD. This can happen because the HD patients should be connected to the machine during dialysis routinely. On the other hand the high rate of suicide in patients with HD were reported due to the violation dietary cloud. INA HEA, Jakarta 2015 23 Independent Variable Dependent Variable FRAMEWORK CONCEPTS Age Gender Education Job Duration of HD Quality of life Duration of CAPD Disease before suffer from ESRD Renal Replacement Total cost of HD Renal Replacement HD ACER HD Patient Quality of life ICER Renal Replacement CAPD Total cost of CAPD ACER CAPD Patient Quality of life INA HEA, Jakarta 2015 24 HYPOTESIS CAPD cost effective compare to HD INA HEA, Jakarta 2015 25 • Cross Sectional • Direct medical cost (INA CBGs) • Indirect medical cost (questionnaire) • Opportunity cost (questionnaire) • Quality of life (SF 36) Location and Time • HD : RS PMI Bogor • CAPD: Patient Home • April – May 2014 • Population: • HD Patient :PMI Bogor Hospital • CAPD Patient: Fatmawati Hospital Population and Sample Research Design INA HEA, Jakarta 2015 26 DIRECT MEDICAL COST : HEMODIALYSIS PACKET (TARIF RS TIPE B, REGIONAL I) 2014 Variable Cost (Rp) Cimino Operation 1.324.036,- Hemodialysis packet Rental Machines and room Medical Fee Consumable HD Set and Hemodialysis fluid drugs and BMHP Blood Transfusion Laboratory Diagnostic investigation Other Cost One Session of HD 982.650,- Cost per year (2 times/week) 102.195.600,- Cost per year (2 times/week) + Cimino Operation 103,519,636,INA HEA, Jakarta 2015 27 DIRECT MEDICAL COST : HEMODIALYSIS PACKET (TARIF RS TIPE A, REGIONAL I) 2014 Variabel Biaya (Rp) Cimino Operation 3.063.114 Hemodialysis packet Rental Machines and room Medical Fee Consumable HD Set and Hemodialysis fluid drugs and BMHP Assumptions calculation from new patients in 2012 Indonesian Renal Registry (IRR) (19.621 patients), BPJS will be burdened Rp.2.031.158.777.956, - when patients get HD in Hospital type B and becomes Rp. 2,877,294,899,682, - when patients received HD in Type A Hospital Blood Transfusion Laboratory Diagnostic investigation Other Cost One Session of HD Cost per year (2 times/week) 1.380.582,143.580.528,- Cost per year (2 times/week) + Cimino Operation 146.643.642,INA HEA, Jakarta 2015 28 CAPD DIRECT MEDICAL COST (TARIF INA CBGS RSUP FATMAWATI) Variable Cost (Rp) Catheter 3.063.114 Routine CAPD Packet Consumable CAPD Set include fluids for 30 days - Dianeal 1,5% = 90 - Dianeal 2,5% = 90 When compared with hemodialysis treatment, the direct medical care cost of - Minicap = 120 Jasa Pengiriman CAPD Set CAPD provide the difference in cost of Rp. 562 662 038 162, - lower or 28% lower than hemodialysis in Type B Hospital and Rp.1.408.798.159.888, - in Type A Hospital or 51 , 04% lower. Medical fee Sub Total Cost 5.940.000,- Routine Packet per year (4 times per day) 71.280.000,- Transfer set every 6 month depend on medical indication 250.000,- Transfer set in one year 500.000,- Cost per year + Transfer set per year Total cost per year 71.780.000,INA HEA, Jakarta 2015 74.843.114,29 DISTRIBUTION OF DIRECT NON MEDICAL COST FOR HEMODIALYSIS PATIENT Transportation Food/Drink HD Cost per session 6.500 5.000 11.500 Max (Rp) 400.000 90.000 490.000 Cost per month (2 session per week) Cost per year 103.500 4.410.000 468.976 240.000 1.236.000 52.920.000 5.627.712 3.120.000 Variable Min (Rp) Mean (Rp) 43.763 14.859 58.622 Median (Rp) 27.500 2.500 30.000 These costs must be quite burden for patients whose income < Rp 500.000, -. Although the direct medical costs not borne by the patient, direct non-medical costs alone is quite a burden for hemodialysis patients. INA HEA, Jakarta 2015 30 LOSS INCOME OF HD PATIENT’S Variable Loss of income per month Patient Family who are waiting during HD session Lost of income per month Lost of income per year Min (Rp) Max (Rp) Mean (Rp) Median - 16.000.000 450.000 16.450.000 197.400.000 1.522.000 280.000 1.802.000 21.624.000 640.000 280.000 920.000 11.040.000 CAPD patients and their families do not have to lose time working for CAPD action. It can be concluded indirect costs of the action CAPD is Rp.0 INA HEA, Jakarta 2015 31 HD VS CAPD QUALITY OF LIFE Variable Whole Sample Less Quality Good Quality HD Patient Less Quality Good Quality CAPD Patient Less Quality Good Quality INA HEA, Jakarta 2015 Total Persentase (%) 43 45 48,9 51,1 42 36 53,8 46,2 1 9 10 90 32 CONECTION BETWEEN INDEPENDENT VARIABLE WITH DEPENDENT VARIABLE (*) : statistical significant Variable Renal Replacement HD CAPD Age < 45 year >= 45 year Gender Man Women Working no Working Education Low High Duration of HD/ CAPD < 4 year >= 4 year Quality of life Leer Quality Good Quality OR (95% CI) P-Value 42 (53,8%) 1 (10,0%) 36 9 (46,2%) (90,0%) 10,5 (1,269-86,901) 0,015* 17 (54,8%) 26 (45,6%) 14 31 (45,2%) (54,4%) 1,448 (0,601-3,486) 0,546 26 (53,1%) 17 (43,6%) 23 22 (46,9%) (56,4%) 1,463 (0,628-3,408) 0,504 35 (57,4%) 8 (29,6%) 26 19 (42,6%) (70,4%) 3,197 (1,213-8,429) 0,030* 6 (54,5%) 37 (48,1%) 5 40 (45,5%) (51,9%) 1,297 (0,365-4,611) 0,936 29 (46,0%) 14 (56,0%) 34 11 (54,0%) (44,0%) 0,670 (0,264-1,702) 0,544 INA HEA, Jakarta 2015 33 QUALITY OF LIFE DIMENSION QoL Dimension Variable N Mean SD T (t-test) P-value CAPD 10 257,500 73,645 -1,257 0,212 Haemodialisa 78 298,718 100,072 CAPD 10 540,000 177,638 0,285 0.777 Haemodialisa 78 514,103 279,830 CAPD 10 300,000 169,967 Haemodialisa 78 98,718 129,427 CAPD 10 270,000 94,868 Haemodialisa 78 111,538 135,781 General Health Physical Function Physical Role 4,464 <0.001* Role of Emotions INA HEA, Jakarta 2015 4,701 <0.001* 34 QUALITY OF LIFE DIMENSION QoL Dimension Variable N Mean SD T (t-test) P-value CAPD 10 182,000 20,709 6,218 <0.001* Haemodialisa 78 124,167 58,334 CAPD 10 324,000 18,378 4,220 <0.001* Haemodialisa 78 275,128 88,460 CAPD 10 180,000 10,540 7,165 <0.001* Haemodialisa 78 131,730 51,703 CAPD 10 420,000 24,944 4,758 <0.001* Haemodialisa 78 354,359 99,968 Pain Energy Social Function Mental Health INA HEA, Jakarta 2015 35 NON PARAMETRIK TEST Uji statistik Kualitas hidup per dimensi Mann-Whitney U-Test Uji statistik Kualitas hidup per dimensi Kolmogorov-Smirnov INA HEA, Jakarta 2015 36 CRONBACH’S ALPHA IF ITEM DELETED No Dimension Cronbach’s Alpha if Item Deleted 1 Emotional Role 0,655 2 Physical Function 0,669 3 Mental Health 0,683 4 Energy 0,708 5 Pain 0,724 6 Social Function 0,726 INA HEA, Jakarta 2015 37 TOTAL HD COST HD INA CBGs OOP Direct Medical Cost Direct Non Medical Cost Indirect Cost Total min max mean median 102,195,600 102,195,600 1,236,000 103,431,600 143,850,528 25,440,000 169,290,528 52,920,000 197,400,000 419,610,528 102,195,600 3,949,380 106,144,980 5,627,712 21,624,000 133,396,692 102,195,600 1,440,000 103,635,600 3,120,000 11,040,000 117,795,600 CAPD Paket CAPD OOP Direct Medical Cost Direct Non Medical Cost Indirect Cost Total 71,780,000 600,000 72,380,000 72,380,000 71,780,000 24,000,000 95,780,000 95,780,000 71,780,000 9,900,000 81,680,000 81,680,000 71,780,000 9,999,996 81,779,996 81,779,996 Data dalam Rp INA HEA, Jakarta 2015 38 EMOSIONAL ROLE CEA ANALYSIS Renal Per year Emotional Replacement ACER Role HD 133.396.692 41,61 Rp 133.396.692/41,61 = 3.205.881,per emotional role CAPD 81.680.000 67,05 Rp 81.680.000/67,05 = 1.218.195,per emotional role ICER CAPD vs HD Dominant for cost and emotional role* CAPD vs HD (Rp 81.680.000 - 133.396.692) / 67,05 – 41,61) = Rp 2.032.889,per extra emotional role *CE(Cost Effectiveness) Plan INA HEA, Jakarta 2015 39 PHYSICAL ROLE CEA ANALYSIS Renal Replacement Per Year Physical ACER Role HD 133.396.692 41,20 Rp 133.396.692/41,20 = 3.237.784,per physical role CAPD 81.680.000 70,25 Rp 81.680.000/70,25 = 1.162.705,per physical role ICER CAPD vs HD Dominant for cost and physical role * CAPD vs HD (Rp 81.680.000 - 133.396.692) / (70,25 41,20) = Rp 1.780.265,- per extra physical role *CE(Cost Effectiveness) Plan INA HEA, Jakarta 2015 40 CE PLAN Cost Differences (+) Effect Diferences (-) Effect Differences (+) Dominant Cost Differences (-) INA HEA, Jakarta 2015 41 Cost of Renal Replacement Cost of CAPD 39% lower than HD (Peeters P 2000) cost analysis HD and CAPD in 25 studies This is in accordance with (Philip 2001), PD 10-40% lower than HD in worldwide CAPD provide a cost advantage compared with hemodialysis INA HEA, Jakarta 2015 42 Statistics Significant : Quality of Life HD vs CAPD (Albert W Wu 2004) peritoneal dialysis have a better quality of life compared with hemodialysis (Peeters P 2000) HD and CAPD cost analysis on 25 studies. CAPD provide a cost advantage compared to hemodialsa (Thong and Adrian a Kaptein 2008) Research using a questionnaire developed by the experts mentioned that dialysis peritoneal dialysis patients score higher than hemodialysis patients on aspects of family life, independence, spiritual condition, energy level, and living conditions (Noshad, et al. 2009), peritoneal dialysis had a statistically significantly better quality of life compared to hemodialysis in patients with diabetes and non-diabetes. Peritoneal dialysis patients have a higher value for all aspects. The positive thing of peritoneal dialysis is due to the addition of energy for feeling alive and well, able to do therapy at home, can do therapy during sleep, and feel independent. Patients in this study also feel good because it can perform CAPD own without requiring the assistance of the medical team Another study in 16 755 patients with hemodialysis and peritoneal dialysis 1,260 patients found that peritoneal dialysis patients had higher scores on the mental dimension compared with hemodialysis patients, using a questionnaire SF 36 (Thong and Adrian a Kaptein 43 INA HEA, Jakarta 2015 2008) (Coccossis, et al. 2008) Hemodialysis patients have more experience in terms of anxiety and sleep disorders that affect the patient's emotions and feel overwhelmed with the strict provisions of the action routine hemodialysis Peritoneal dialysis patients in the 65 analysis meta studies showed that peritoneal dialysis patients have better characteristics and stress less than hemodialysis patients (Thong and Adrian a Kaptein 2008) Hemodialysis patient dissatisfaction can be caused by stress facing dialysis procedure, the high frequency of visits to the hospital, waiting time in hemodialysis units and treatment of medical personnel at the hospital. Hemodialysis patients have symptoms of depression are higher and tend to commit suicide besides having depressive symptomatology INA HEA, Jakarta 2015 44 ROLE OF PHYSICAL CAPD patient satisfaction increased as the opportunity to do a better recreation in terms of transportation, the opportunity to obtain information, better life and the opportunity to gain new skills . (Coccossis et al. 2008). 2/3 patients receiving dialysis therapy never return to normal activities or work, and many patients lose their jobs CAPD patients allowed to travel every day, can work to earn more and dialysis can be done anywhere (Nurchayati 2010) (Coccossis, et al. 2008). INA HEA, Jakarta 2015 45 CONCLUSION 1. CAPD costs 39% lower than HD 2. Patients receiving hemodialysis measures 10.5 times more likely to have less quality of life compared with patients receiving CAPD 3. CAPD patient's quality of life is better compared with hemodialysis patients in the physical dimensions of the role, the role of emotions, pain, energy, social functioning and mental health (proven statistically) 4. CAPD action is more cost effective than hemodialysis INA HEA, Jakarta 2015 46 ADVICE FOR PATIENT Looking for information related to kidney disease Finding the advantages and disadvantages of every kind of renal replacement therapy Choosing CAPD if there are no complications to walk on CAPD INA HEA, Jakarta 2015 47 ADVICE FOR HOSPITAL The team of doctors at the hospital are expected to assist the patient in deciding the type of renal replacement therapy in accordance with the patient and provide more benefits for patient Provide a complete and detailed description of hemodialysis and CAPD before the patient decides the selected action either directly to patients or in health seminars forums Ensuring Patient CAPD fluid available from distributors and delivered directly to the patient's home. Do not take additional cost from patient if all of its services has been included in the package hemodialysis or CAPD Communicate with doctors, not prescribed expensive drugs, because patients take medications regularly INA HEA, Jakarta 2015 48 BPJS KESEHATAN Approach to the hospital in order to make CAPD as first choice Encourage the patient to take hemodialysis in lower type hospital if the patient is not allowed to take CAPD CAPD action socializing through BPJS Center officer in hospital and through seminars Monitor and coordinate with the hospital to make sure there is no additional costs are charged to the patient's with hemodialysis and CAPD INA HEA, Jakarta 2015 49 THE GOVERNMENT Increase the number of hospitals that are able to provide services CAPD Ensuring CAPD fluid supply imported from abroad are available and controlling costs so that the liquid is not too high Analyze the possibility of CAPD fluid produced in Indonesia when there will be increasing number of CAPD patients in the future CAPD campaigning as the first choice of renal replacement therapy for patients with ESRD Evaluate the hospital that still take additional costs from HD and CAPD Evaluate the INA CBGs rates for dialysis procedures INA HEA, Jakarta 2015 50 THANK YOU INA HEA, Jakarta 2015 51